93 related articles for article (PubMed ID: 7237409)
21. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
Chang HR; Cole B; Bland KI
J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
[TBL] [Abstract][Full Text] [Related]
22. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
[TBL] [Abstract][Full Text] [Related]
23. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
24. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma.
Bland KI; Kuhns JG; Buchanan JB; Dwyer PA; Heuser LF; O'Connor CA; Gray LA; Polk HC
Ann Surg; 1982 May; 195(5):582-94. PubMed ID: 7073355
[TBL] [Abstract][Full Text] [Related]
26. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
28. Lung cancer screening results in the National Cancer Institute New York study.
Melamed MR
Cancer; 2000 Dec; 89(11 Suppl):2356-62. PubMed ID: 11147612
[TBL] [Abstract][Full Text] [Related]
29. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Wildiers H; Tryfonidis K; Dal Lago L; Vuylsteke P; Curigliano G; Waters S; Brouwers B; Altintas S; Touati N; Cardoso F; Brain E
Lancet Oncol; 2018 Mar; 19(3):323-336. PubMed ID: 29433963
[TBL] [Abstract][Full Text] [Related]
30. Nonpalpable invasive breast cancer.
Wilhelm MC; Edge SB; Cole DD; deParedes E; Frierson HF
Ann Surg; 1991 Jun; 213(6):600-3; discussion 603-5. PubMed ID: 2039291
[TBL] [Abstract][Full Text] [Related]
31. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
32. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
Miller AB; To T; Baines CJ; Wall C
J Natl Cancer Inst; 2000 Sep; 92(18):1490-9. PubMed ID: 10995804
[TBL] [Abstract][Full Text] [Related]
33. The detection of early breast cancer: three-year results from a diagnostic breast clinic.
Hirst C; Furnival CM; Fielding GD; Porter AJ
Med J Aust; 1987 Oct; 147(7):328-30. PubMed ID: 3309588
[TBL] [Abstract][Full Text] [Related]
34. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.
Clark RM; Whelan T; Levine M; Roberts R; Willan A; McCulloch P; Lipa M; Wilkinson RH; Mahoney LJ
J Natl Cancer Inst; 1996 Nov; 88(22):1659-64. PubMed ID: 8931610
[TBL] [Abstract][Full Text] [Related]
35. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V; Cole BF; Viale G; Veronesi P; Vicini E; Intra M; Mazzarol G; Massarut S; Zgajnar J; Taffurelli M; Littlejohn D; Knauer M; Tondini C; Di Leo A; Colleoni M; Regan MM; Coates AS; Gelber RD; Goldhirsch A;
Lancet Oncol; 2018 Oct; 19(10):1385-1393. PubMed ID: 30196031
[TBL] [Abstract][Full Text] [Related]
36. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L
J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer in situ: a retrospective review of 23 cases with a minimum of 10-year followup.
Jubelirer SJ
W V Med J; 1990 Apr; 86(4):141-4. PubMed ID: 2327090
[TBL] [Abstract][Full Text] [Related]
38. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
39. The detection and diagnosis of early, occult and minimal breast cancer.
Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
Adv Surg; 1976; 10():287-312. PubMed ID: 185891
[TBL] [Abstract][Full Text] [Related]
40. Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons.
Bedwani R; Vana J; Rosner D; Schmitz RL; Murphy GP
Cancer; 1981 Jun; 47(12):2769-78. PubMed ID: 7260868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
